Dimensional Fund Advisors LP cut its position in shares of Delek US Holdings, Inc. (NYSE:DK – Free Report) by 3.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,023,784 shares of the oil and gas company’s stock after selling 158,262 shares during the quarter. Dimensional Fund Advisors LP owned approximately 6.27% of Delek US worth $99,629,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. SIR Capital Management L.P. increased its position in shares of Delek US by 37.2% during the 2nd quarter. SIR Capital Management L.P. now owns 876,133 shares of the oil and gas company’s stock valued at $21,693,000 after purchasing an additional 237,734 shares during the last quarter. Bridgeway Capital Management LLC boosted its stake in Delek US by 3.1% in the fourth quarter. Bridgeway Capital Management LLC now owns 777,576 shares of the oil and gas company’s stock valued at $20,061,000 after acquiring an additional 23,509 shares during the last quarter. Norges Bank bought a new position in shares of Delek US during the 4th quarter valued at approximately $16,341,000. Charles Schwab Investment Management Inc. grew its position in shares of Delek US by 2.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 620,957 shares of the oil and gas company’s stock valued at $16,021,000 after acquiring an additional 13,238 shares during the period. Finally, Easterly Investment Partners LLC lifted its stake in Delek US by 26.7% in the second quarter. Easterly Investment Partners LLC now owns 457,536 shares of the oil and gas company’s stock valued at $11,329,000 after purchasing an additional 96,531 shares during the last quarter. 97.01% of the stock is owned by institutional investors.
Delek US Trading Down 3.0 %
Shares of DK stock opened at $19.08 on Wednesday. The business has a 50-day moving average of $20.84 and a 200 day moving average of $25.06. The company has a debt-to-equity ratio of 2.50, a current ratio of 0.98 and a quick ratio of 0.58. Delek US Holdings, Inc. has a 1-year low of $18.35 and a 1-year high of $33.60. The stock has a market capitalization of $1.22 billion, a PE ratio of -15.39 and a beta of 1.14.
Delek US Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, August 19th. Shareholders of record on Monday, August 12th were given a $0.255 dividend. This is a boost from Delek US’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend was Monday, August 12th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 5.35%. Delek US’s payout ratio is presently -82.26%.
Insider Activity
In other Delek US news, CEO Avigal Soreq acquired 5,651 shares of the company’s stock in a transaction on Friday, August 9th. The stock was acquired at an average price of $20.42 per share, for a total transaction of $115,393.42. Following the acquisition, the chief executive officer now owns 188,881 shares in the company, valued at approximately $3,856,950.02. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.80% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on DK shares. Morgan Stanley lowered their price target on shares of Delek US from $24.00 to $22.00 and set an “underweight” rating on the stock in a research report on Monday, September 16th. Wolfe Research began coverage on Delek US in a report on Thursday, July 18th. They set an “underperform” rating and a $19.00 price objective for the company. Piper Sandler cut their price target on shares of Delek US from $25.00 to $19.00 and set a “neutral” rating for the company in a research note on Friday, September 20th. StockNews.com cut shares of Delek US from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, JPMorgan Chase & Co. upgraded shares of Delek US from an “underweight” rating to a “neutral” rating and upped their target price for the stock from $23.00 to $26.00 in a research report on Tuesday, September 10th. Five research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $24.73.
View Our Latest Stock Report on Delek US
Delek US Company Profile
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
See Also
- Five stocks we like better than Delek US
- What is a buyback in stocks? A comprehensive guide for investors
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- About the Markup Calculator
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding DK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Delek US Holdings, Inc. (NYSE:DK – Free Report).
Receive News & Ratings for Delek US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delek US and related companies with MarketBeat.com's FREE daily email newsletter.